1,509 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Declines Amid Heavy Options Activity

Options Event and Cash Market Price Action

The most active call options on Sun Pharmaceutical Industries Ltd on 2 Apr 2026 were those with a strike price of Rs 1,660 expiring on 28 Apr 2026. A total of 1,509 contracts traded, generating a turnover of approximately Rs 294.92 lakhs. The open interest at this strike stands at 743 contracts, indicating that the volume traded was roughly double the existing open interest. This contracts-to-OI ratio of about 2:1 suggests a significant influx of fresh positions rather than mere recycling of existing ones. Sun Pharma’s underlying price hovered at Rs 1,661.40, placing the strike almost exactly at-the-money (ATM).

The cash market, however, showed a contrasting picture. The stock has been on a four-day losing streak, shedding 8.35% in that period, and underperformed its sector by 1.48% on the day. It opened with a gap down of 3.67% and touched an intraday low of Rs 1,620, down 6.28% from the previous close. This divergence between heavy call buying and declining stock price invites a closer look at the nature of the options positioning — is the options market anticipating a reversal or hedging against downside risk?

Strike Price and Moneyness Analysis

The Rs 1,660 strike price is effectively at-the-money given the underlying price of Rs 1,661.40. At-the-money calls are the most sensitive to changes in the underlying price, exhibiting the highest gamma. This means that the option’s value will react sharply to even small movements in the stock price. The concentration of call contracts at this strike suggests a directional bet on near-term price movement rather than a speculative bet on distant upside or a hedge deep in-the-money.

Given the proximity of the strike to the current price, the call activity signals a conviction that the stock is at a critical juncture. Traders may be positioning for a potential bounce or a short-term rally ahead of the expiry on 28 Apr 2026, which is less than four weeks away. The near-term expiry adds urgency to the bet, implying that the options market expects meaningful price action soon — but will the cash market confirm this outlook?

Open Interest and Contracts Analysis

The open interest of 743 contracts at the Rs 1,660 strike is moderate relative to the 1,509 contracts traded on the day. This contracts-to-OI ratio of approximately 2:1 is indicative of fresh money entering the market rather than existing holders adjusting their positions. Such a ratio is notable because it points to new directional bets being placed rather than mere position squaring or rolling.

However, the open interest level itself is not particularly high, which suggests that while the strike is active, it is not yet a dominant focal point in the options chain. The fresh call buying at this strike could be speculative or tactical, possibly reflecting short-term hedging or anticipation of a technical rebound. The expiry date being less than a month away further supports the interpretation of a short-term directional wager.

Cash Market Context and Technical Indicators

The cash market performance of Sun Pharmaceutical Industries Ltd has been weak in recent sessions. The stock trades below all major moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — indicating a bearish technical setup. The sustained decline over four days and the gap down opening on 2 Apr 2026 reinforce this negative momentum.

Interestingly, delivery volumes on 1 Apr rose by 33.93% to 24.1 lakh shares compared to the five-day average, signalling increased investor participation despite the price weakness. This rise in delivery volume suggests that the cash market is not entirely devoid of conviction, even as the price falls. The options market’s heavy call activity at the ATM strike may be reflecting anticipation of a technical support or a short-term reversal — but can the stock overcome its bearish moving average alignment?

Delivery Volume and Market Liquidity

Liquidity in Sun Pharma remains adequate, with the stock’s traded value supporting a trade size of approximately Rs 10.85 crore based on 2% of the five-day average traded value. The rising delivery volume contrasts with the falling price, indicating that some investors are accumulating shares despite the downtrend. This dynamic adds nuance to the options activity, as the derivatives market may be pricing in a near-term bounce while the cash market reflects ongoing selling pressure.

Key Data at a Glance

Conclusion: What the Options and Cash Data Suggest

The heavy call option activity at the Rs 1,660 strike price on Sun Pharmaceutical Industries Ltd represents a concentrated short-term directional bet. The strike’s at-the-money status combined with a contracts-to-open interest ratio of 2:1 points to fresh positioning rather than position adjustments. However, the stock’s recent four-day decline and trading below all major moving averages indicate prevailing bearish momentum in the cash market.

Rising delivery volumes amid falling prices add complexity, suggesting some accumulation despite the downtrend. The options market may be anticipating a near-term reversal or a technical bounce ahead of the 28 Apr expiry, but the cash market’s technical setup remains challenging. is this divergence signalling a genuine recovery or a temporary pause in selling pressure?

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today